LncRNA EGFR-AS1 Modulates Ferroptosis to Decrease Cervical Cancer Radiosensitivity via the m6A/IGF2BP3/APAF1 Pathway - Top-Institutions - MDSpire

LncRNA EGFR-AS1 Modulates Ferroptosis to Decrease Cervical Cancer Radiosensitivity via the m6A/IGF2BP3/APAF1 Pathway

By
Xianglong Chen
Jingyu Li
Yujie Sun
Zhaoyu Ye
Man Long
Junguo Bu
Zirong Fan
Zhaojing Jiang
March 5, 2026
0 min

Bmc Cancer

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

#1

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Gynecologic Oncology
- Radiation Oncology
- Cancer Molecular Biology
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Gynecologic Oncology
- Radiation Oncology
- Cancer Biology
#3

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Medical Oncology
- Radiation Oncology
- Cancer Epigenetics
#4

University of Texas Southwestern Medical Center

Dallas, TX
Key Differentiators
- Cancer Biology
- Radiation Oncology
- Molecular Oncology
#5

Johns Hopkins University

Baltimore, MD
Key Differentiators
- Gynecologic Oncology
- Radiation Oncology
- Cancer Molecular Biology

Original Source(s)

Bmc Cancer

LncRNA EGFR-AS1 Modulates Ferroptosis to Decrease Cervical Cancer Radiosensitivity via the m6A/IGF2BP3/APAF1 Pathway

by Xianglong Chen, Jingyu Li, Yujie Sun, Zhaoyu Ye, Man Long, Junguo Bu, Zirong Fan, Zhaojing Jiang
March 5, 2026

Related Content

European Radiology

Evaluation of MRI for initial staging of esophageal cancer: the STIRMCO study

Conexiant

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

by Kerri Miller
January 15, 2026
3 min

Journal Of Neuro-Oncology

Recurrent meningioma treated with boron neutron capture therapy: a feasibility study with dosimetric and clinical correlates